The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care
Open accessAbstract
Introduction: Infection is an important complication in cancer patients, which frequently leads to or prolongs hospitalization, and can also lead to acute organ dysfunction (severe sepsis) and eventually death. While cancer patients are known to be at higher risk for infection and subsequent complications, there is no national estimate of the magnitude of this problem. Our objective was to identify cancer patients with severe sepsis and to project these numbers to national levels. Methods: Data for all 1999 hospitalizations from six states (Florida, Massachusetts, New Jersey, New York, Virginia, and Washington) were merged with US Census data, Centers for Disease Control vital statistics and National Cancer Institute, Surveillance, Epidemiology, and End Results initiative cancer prevalence data. Malignant neoplasms were identified by International Classification of Disease (ninth revision, clinical modification) (ICD-9-CM) codes (140–208), and infection and acute organ failure were identified from ICD-9-CM codes following Angus and colleagues. Cases were identified as a function of age and were projected to national levels. Results: There were 606,176 cancer hospitalizations identified, with severe sepsis present in 29,795 (4.9%). Projecting national estimates for the US population, cancer patients account for 126,209 severe sepsis cases annually, or 16.4 cases per 1000 people with cancer per year. The inhospital mortality for cancer patients with severe sepsis was 37.8%. Compared with the overall population, cancer patients are much more likely to be hospitalized (relative risk, 2.77; 95% confidence interval, 2.77–2.78) and to be hospitalized with severe sepsis (relative risk, 3.96; 95% confidence interval, 3.94–3.99). Overall, severe sepsis is associated with 8.5% (46,729) of all cancer deaths at a cost of $3.4 billion per year. Conclusion: Severe sepsis is a common, deadly, and costly complication in cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Self-citationEpidemiology of Sepsis Syndrome in 8 Academic Medical Centers
Sands, K. E. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550030074038 · Cited by 663
Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment
Zeni, F., Freeman, B., & Natanson, C. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00001 · Cited by 648
Survival of Medicare Patients after Enrollment in Hospice Programs
Christakis, N. A., & Escarce, J. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607183350306 · Cited by 537
The Burden of Illness of Cancer: Economic Cost and Quality of Life
Brown, M. L., Lipscomb, J., & Snyder, C. (2001) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.22.1.91 · Cited by 309
Infection in cancer patients: A continuing association
Bodey, G. P. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90510-3 · Cited by 292
Intensive care, survival, and expense of treating critically ill cancer patients
Schapira, D. V. (1993) · JAMA · doi:10.1001/jama.269.6.783 · Cited by 192
Outcome of bone marrow transplantation patients requiring mechanical ventilation
Huaringa, A. J., Leyva, F. J., Giralt, S. A., Blanco, J., Signes‐Costa, J., Velarde, H., & Champlin, R. E. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004000-00017 · Cited by 151
Dejace, P., & Klastersky, J. A. (1989) · Springer eBooks · doi:10.1007/978-3-642-72646-0_24 · Cited by 82
Evolving Risk Factors for Infectious Complications of Cancer Therapy
Chanock, S. J. (1993) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30221-1 · Cited by 80
Outcomes Research in Surgical Oncology
Porter, G. A., & Skibber, J. M. (2000) · Annals of Surgical Oncology · doi:10.1007/s10434-000-0367-4 · Cited by 35
INTENSIVE CARE, MECHANICAL VENTILATION, DIALYSIS, AND CARDIOPULMONARY RESUSCITATION
Groeger, J. S., & Aurora, R. N. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70208-6 · Cited by 34
Rosenman, M. B., Madsen, K. A., Hui, S. L., & Breitfeld, P. P. (2002) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200205000-00009 · Cited by 24
Sepsis in Immunocompromised Hosts
Conlon, C. P. (2000) · Journal of the Royal College of Physicians of London · doi:10.1016/s0035-8819(25)01440-0 · Cited by 5
Cited by
Hotchkiss, R. S., Moldawer, L. L., Opal, S. M., Reinhart, K., Turnbull, I. R., & Vincent, J.-L. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.45 · Cited by 1,620
Sepsis: pathophysiology and clinical management
Gotts, J. E., & Matthay, M. A. (2016) · BMJ · doi:10.1136/bmj.i1585 · Cited by 1,243
Mayr, F. B., Yende, S., & Angus, D. C. (2014) · Virulence · doi:10.4161/viru.27372 · Cited by 1,208
Effect of removing Kupffer cells on nanoparticle tumor delivery
Tavares, A. J., Poon, W., Zhang, Y.-N., Dai, Q., Besla, R., Ding, D., Ouyang, B., Li, A., Chen, J., Zheng, G., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713390114 · Cited by 286
O’Brien, J. M., Lu, B., Ali, N. A., Martin, G. S., Aberegg, S. K., Marsh, C. B., Lemeshow, S., & Douglas, I. S. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000254340.91644.b2 · Cited by 258
Metadata
- Authors
- Williams, M. D., Braun, L. A., Cooper, L. M., Johnston, J., Weiss, R. V., Qualy, R. L., & Linde-Zwirble, W.
- Venue
- Critical Care
- Published
- 2004-07-05
- Volume
- 8
- Issue
- 5
- Pages
- R291-8
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W2127860293
- Cited by
- 364
- References
- 15
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
